PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1646924-4	1991	In contrast, a single dose of the reversible monoamine oxidase type A (MAO-A) inhibitor moclobemide reduced plasma DHPG levels by 78% and MHPG levels by 51%.	3,4-dihydroxyphenylglycol	115-119	monoamine oxidase A	Homo sapiens	45-69	
15671203-4	2005	MAO-A activity was estimated by measuring concentrations of 3,4-dihydroxyphenylglycol (DHPG), a stable metabolite of norepinephrine.	3,4-dihydroxyphenylglycol	60-85	monoamine oxidase A	Homo sapiens	0-5	
15671203-4	2005	MAO-A activity was estimated by measuring concentrations of 3,4-dihydroxyphenylglycol (DHPG), a stable metabolite of norepinephrine.	3,4-dihydroxyphenylglycol	87-91	monoamine oxidase A	Homo sapiens	0-5	
15801935-4	2005	MAO-A activity in plasma was estimated by measuring plasma concentrations of 3,4-dihydroxyphenylglycol.	3,4-dihydroxyphenylglycol	77-102	monoamine oxidase A	Homo sapiens	0-5	
1347659-5	1992	The inhibitory activity of moclobemide on MAO-A was reflected in significant reductions of plasma concentrations of DHPG and 5-HIAA.	3,4-dihydroxyphenylglycol	116-120	monoamine oxidase A	Homo sapiens	42-47	
1646924-4	1991	In contrast, a single dose of the reversible monoamine oxidase type A (MAO-A) inhibitor moclobemide reduced plasma DHPG levels by 78% and MHPG levels by 51%.	3,4-dihydroxyphenylglycol	115-119	monoamine oxidase A	Homo sapiens	71-76	
1646924-5	1991	It is concluded that the plasma concentrations of DHPG and MHPG are largely determined by intraneuronal, MAO-A-dependent metabolism of NE, and do not accurately reflect acute alterations in neuronal NE release.	3,4-dihydroxyphenylglycol	50-54	monoamine oxidase A	Homo sapiens	105-110	
2250565-3	1990	MAO-A inhibition, as evidenced by up to 80% decreases in the plasma concentration of 3,4-dihydroxyphenylglycol, a deaminated metabolite of norepinephrine, was similar after both pretreatments.	3,4-dihydroxyphenylglycol	85-110	monoamine oxidase A	Homo sapiens	0-5	
2469451-9	1989	Due to the rapid, reversible, dose-dependent and MAO-A specific effect of moclobemide on plasma concentrations of DHPG, it is suggested that DHPG in plasma may be a useful indicator of the magnitude and duration of MAO-A inhibition in man.	3,4-dihydroxyphenylglycol	114-118	monoamine oxidase A	Homo sapiens	49-54	
2817346-1	1989	The monoamine oxidase A metabolite of noradrenaline, 3,4-dihydroxyphenylglycolaldehyde, is the precursor of 3,4-dihydroxymandelic acid, and 3,4-dihydroxyphenylglycol, metabolites of noradrenaline.	3,4-dihydroxyphenylglycol	53-78	monoamine oxidase A	Homo sapiens	4-23	
19733607-5	2009	The MAO-A-dependent catecholamine metabolite DHPG levels did not change significantly during the study suggesting that rasagiline"s MAO-B selectivity was preserved.	3,4-dihydroxyphenylglycol	45-49	monoamine oxidase A	Homo sapiens	4-9